GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Nanosphere Inc (NAS:NSPH) » Definitions » 5-Year RORE %

Nanosphere (Nanosphere) 5-Year RORE % : 0.00% (As of Mar. 2016)


View and export this data going back to 2007. Start your Free Trial

What is Nanosphere 5-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Nanosphere's 5-Year RORE % for the quarter that ended in Mar. 2016 was 0.00%.

The industry rank for Nanosphere's 5-Year RORE % or its related term are showing as below:

NSPH's 5-Year RORE % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.04
* Ranked among companies with meaningful 5-Year RORE % only.

Nanosphere 5-Year RORE % Historical Data

The historical data trend for Nanosphere's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosphere 5-Year RORE % Chart

Nanosphere Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
5-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Nanosphere Quarterly Data
Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Nanosphere's 5-Year RORE %

For the Diagnostics & Research subindustry, Nanosphere's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanosphere's 5-Year RORE % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Nanosphere's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Nanosphere's 5-Year RORE % falls into.



Nanosphere 5-Year RORE % Calculation

Nanosphere's 5-Year RORE % for the quarter that ended in Mar. 2016 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( -5.385--16.538 )/( -53.849-0 )
=11.153/-53.849
=-20.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2016 and 5-year before.


Nanosphere  (NAS:NSPH) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Nanosphere 5-Year RORE % Related Terms

Thank you for viewing the detailed overview of Nanosphere's 5-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanosphere (Nanosphere) Business Description

Traded in Other Exchanges
N/A
Address
Nanosphere, Inc., was incorporated in 1999 in Delaware. The Company develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, that enables sensitive genomic and protein testing on a single platform. The Verigene System includes a bench-top molecular diagnostics workstation that is an advanced platform for genomic and protein testing. The Verigene System includes a bench-top molecular diagnostics workstation that is a universal platform for genomic and protein testing. The Verigene System provides lower cost for laboratories already performing molecular diagnostic testing and enables smaller laboratories and hospitals without advanced diagnostic capabilities to perform genetic testing.
Executives
Michael James Ward director 440 W. ONTARIO ST., CHICAGO IL 60654
Lorin Randall director C/O ACORDA THERAPEUTICS, INC., 420 SAW MILL RIVER ROAD, ARDSLEY NY 10502
R. Erik Holmlin director 4088 COMMERCIAL AVE., NORTHBROOK IL 60062
Gene S Cartwright director 4088 COMMERCIAL AVE, NORTHBROOK IL 60062
Mmcap International Inc. Spc 10 percent owner C/O MOURANT GOVERNANCE SVCS (CAYMAN) LTD, 94 SOLARIS AVE., CAMANA BAY, PO BOX 1348, GRAND CAYMAN E9 KY1-1108
Ann Wallin officer: Interim CFO 4088 COMMERCIAL AVENUE, NORTHBROOK IL 60062
Bruin Andre De director
Sheli Z Rosenberg director C/O EQUITY GROUP INVESTMENTS, L.L.C., TWO NORTH RIVERSIDE PLAZA, SUITE 600, CHICAGO IL 60606
Chad A. Mirkin director 4088 COMMERCIAL AVENUE, NORTHBROOK IL 60062
Brookside Capital Management Llc 10 percent owner C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Brookside Capital Partners Fund Lp 10 percent owner C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Brookside Capital Investors L P 10 percent owner C/O BAIN CAPITAL PUBLIC EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Fund 2005, L.p. 10 percent owner C/O BAIN CAPITAL, LLC, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Partners 2005, L.p. 10 percent owner C/O BAIN CAPITAL, LLC, JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Venture Investors, Llc 10 percent owner 200 CLARENDON STREET, BOSTON MA 02116

Nanosphere (Nanosphere) Headlines

From GuruFocus

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk 11-05-2009

New Optical Disks May Boost the Gold Nanoparticles Industry

By Alberto Abaterusso Alberto Abaterusso 03-27-2018

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk 05-06-2010

NANOSPHERE, INC. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010